Radiotherapy Induced Middle Ear Morbidities in Head and Neck Cancer Patients

Introduction Although post radiotherapy (RT) otological complications are complex and common, there is lack of data on its severity and spectrum. We intend to assess the incidence and severity of such ototoxicities in head neck cancer (HNCA) patients.  Materials and Methods One year prospective s...

Full description

Bibliographic Details
Main Authors: Adity Chakraborty, Abhinandan Bhattacharjee, Arnab Purakaystha, Aakanksha Rathor, Ridip Mazumdar
Format: Article
Language:English
Published: The Association of Otolaryngologists of India, West Bengal 2021-06-01
Series:Bengal Journal of Otolaryngology and Head Neck Surgery
Subjects:
Online Access:https://bjohns.in/journal3/index.php/bjohns/article/view/432
_version_ 1827334231835017216
author Adity Chakraborty
Abhinandan Bhattacharjee
Arnab Purakaystha
Aakanksha Rathor
Ridip Mazumdar
author_facet Adity Chakraborty
Abhinandan Bhattacharjee
Arnab Purakaystha
Aakanksha Rathor
Ridip Mazumdar
author_sort Adity Chakraborty
collection DOAJ
description Introduction Although post radiotherapy (RT) otological complications are complex and common, there is lack of data on its severity and spectrum. We intend to assess the incidence and severity of such ototoxicities in head neck cancer (HNCA) patients.  Materials and Methods One year prospective study was conducted on thirty cases of HNCA receiving radiotherapy. Audiometry and tympanometry changes were noted and severity is assessed using Common Toxicity Criteria (CTC) -v2.0 of the National Cancer Institute (NCI). Fisher's Exact Test with two-sided p value was used for comparison of the tympanometric changes. Results The mean age was 55.4 years. The commonest site of HNCA was oral cavity (30%) with  46.6 % in stage II. 40% of cases were in grade II, followed by 27% cases in Grade III. The commonest complaint was pain (86.6%), hearing loss (80%) and 40% post-RT cases reporting Type B curve (relative risk 0.67). Conclusion Post-irradiation pain and OME are a major concern in HNCA patients having grade II (NCI-CTC). Early detection and prophylactic measures will improve the quality of life in such group of patients.  This result validates the need for formulating otological diagnostic strategy & therapeutic measures in patients receiving RT to mitigate post-irradiation ototoxicities.
first_indexed 2024-03-07T17:49:22Z
format Article
id doaj.art-f28428dc1eff4e0a8e2a8962ed5d19bb
institution Directory Open Access Journal
issn 2395-2407
language English
last_indexed 2024-03-07T17:49:22Z
publishDate 2021-06-01
publisher The Association of Otolaryngologists of India, West Bengal
record_format Article
series Bengal Journal of Otolaryngology and Head Neck Surgery
spelling doaj.art-f28428dc1eff4e0a8e2a8962ed5d19bb2024-03-02T14:25:18ZengThe Association of Otolaryngologists of India, West BengalBengal Journal of Otolaryngology and Head Neck Surgery2395-24072021-06-01291Radiotherapy Induced Middle Ear Morbidities in Head and Neck Cancer PatientsAdity Chakraborty0Abhinandan Bhattacharjee1 Arnab Purakaystha2Aakanksha Rathor3 Ridip Mazumdar4Guwahati Medical College, ASsam 781006Silchar Medical College, Assam, 788014Silchar Medical College, Assam, 788014 Stanford University School of Medicine, CA, USASilchar Medical College, Assam 788014Introduction Although post radiotherapy (RT) otological complications are complex and common, there is lack of data on its severity and spectrum. We intend to assess the incidence and severity of such ototoxicities in head neck cancer (HNCA) patients.  Materials and Methods One year prospective study was conducted on thirty cases of HNCA receiving radiotherapy. Audiometry and tympanometry changes were noted and severity is assessed using Common Toxicity Criteria (CTC) -v2.0 of the National Cancer Institute (NCI). Fisher's Exact Test with two-sided p value was used for comparison of the tympanometric changes. Results The mean age was 55.4 years. The commonest site of HNCA was oral cavity (30%) with  46.6 % in stage II. 40% of cases were in grade II, followed by 27% cases in Grade III. The commonest complaint was pain (86.6%), hearing loss (80%) and 40% post-RT cases reporting Type B curve (relative risk 0.67). Conclusion Post-irradiation pain and OME are a major concern in HNCA patients having grade II (NCI-CTC). Early detection and prophylactic measures will improve the quality of life in such group of patients.  This result validates the need for formulating otological diagnostic strategy & therapeutic measures in patients receiving RT to mitigate post-irradiation ototoxicities.https://bjohns.in/journal3/index.php/bjohns/article/view/432Head and Neck NeoplasmsRadiotherapyMorbidity, EarProspective Study
spellingShingle Adity Chakraborty
Abhinandan Bhattacharjee
Arnab Purakaystha
Aakanksha Rathor
Ridip Mazumdar
Radiotherapy Induced Middle Ear Morbidities in Head and Neck Cancer Patients
Bengal Journal of Otolaryngology and Head Neck Surgery
Head and Neck Neoplasms
Radiotherapy
Morbidity, Ear
Prospective Study
title Radiotherapy Induced Middle Ear Morbidities in Head and Neck Cancer Patients
title_full Radiotherapy Induced Middle Ear Morbidities in Head and Neck Cancer Patients
title_fullStr Radiotherapy Induced Middle Ear Morbidities in Head and Neck Cancer Patients
title_full_unstemmed Radiotherapy Induced Middle Ear Morbidities in Head and Neck Cancer Patients
title_short Radiotherapy Induced Middle Ear Morbidities in Head and Neck Cancer Patients
title_sort radiotherapy induced middle ear morbidities in head and neck cancer patients
topic Head and Neck Neoplasms
Radiotherapy
Morbidity, Ear
Prospective Study
url https://bjohns.in/journal3/index.php/bjohns/article/view/432
work_keys_str_mv AT aditychakraborty radiotherapyinducedmiddleearmorbiditiesinheadandneckcancerpatients
AT abhinandanbhattacharjee radiotherapyinducedmiddleearmorbiditiesinheadandneckcancerpatients
AT arnabpurakaystha radiotherapyinducedmiddleearmorbiditiesinheadandneckcancerpatients
AT aakanksharathor radiotherapyinducedmiddleearmorbiditiesinheadandneckcancerpatients
AT ridipmazumdar radiotherapyinducedmiddleearmorbiditiesinheadandneckcancerpatients